The introduction of small-molecule pharmacological chaperones as therapeutics for protein misfolding diseases has proven challenging partly because their mechanism of action remains unclear. condition delaying indigenous refolding. Furthermore Fe-TMPyP binding blocks the forming of a well balanced misfolded dimer by…